Læknablaðið - nóv. 2019, Blaðsíða 35

LÆKNAblaðið 2019/105 507
Y F I R L I T
1. Li Y, Zhang Y, Zhang Y. Research advances in pathogenes-
is and prophylactic measures of acute high altitude illness.
Respir Med 2018; 145: 145-52.
2. Davis C, Hackett P. Advances in the Prevention and
Treatment of High Altitude Illness. Emerg Med Clin North
Am 2017; 35: 241-60.
4. Guðmundsson G, Guðbjartsson T. Hæðarveiki - yfirlits-
grein. Læknablaðið 2009; 95: 441-7.
5. Basnyat B, Hofmeyr R, Tolken G, De Decker R. Acute
high-altitude illness. S Afr Med J 2017; 107: 1047-8.
7. Luks AM, Auerbach PS, Freer L, Grissom CK, Keyes LE5
McIntosh SE, et al. Wilderness Medical Society Practice
Guidelines for the Prevention and Treatment of Acute
Altitude Illness: 2019 Update. Wilderness Environ Med
2019; pii: S1080-6032(19)30090-0.
9. Smedley T, Grocott MP. Acute high-altitude illness: a
clinically orientated review. Br J Pain 2013; 7: 85-94.
10. Villafuerte FC, Corante N. Chronic Mountain Sickness:
Clinical Aspects, Etiology, Management, and Treatment.
High Alt Med Biol 2016; 17: 61-9.
11. Corante N, Anza-Ramirez C, Figueroa-Mujica R,
Macarlupú JL, Vizcardo-Galindo G, Bilo G, et al. Excessive
Erythrocytosis and Cardiovascular Risk in Andean
Highlanders. High Alt Med Biol 2018; 19: 221-31.
12. Schoene RB. Illnesses at high altitude. Chest 2008; 134: 402-
16.
14. Grocott MP, Martin DS, Levett DZ, McMorrow R, Windsor
J, Montgomery HE, et al. Arterial blood gases and oxygen
content in climbers on Mount Everest. N Engl J Med 2009;
360: 140-9.
16. Bartsch P, Gibbs JS. Effect of altitude on the heart and the
lungs. Circulation 2007; 116: 2191-202.
17. Bartsch P, Swenson ER. Acute high-altitude illnesses. N
Engl J Med 2013; 369: 1666-7.
18. Hoppeler H, Vogt M, Weibel ER, Fluck M. Response of
skeletal muscle mitochondria to hypoxia. Exp Physiol
2003; 88: 109-19.
19. Murray AJ, Horscroft JA. Mitochondrial function at
extreme high altitude. J Physiol 2016; 594: 1137-49.
20. Murray AJ, Montgomery HE, Feelisch M, Grocott MPW,
Martin DS. Metabolic adjustment to high-altitude hypox-
ia: from genetic signals to physiological implications.
Biochem Soc Trans 2018; 46: 599-607.
22. Roach RC, Hackett PH, Oelz O, Bärtsch P, Luks AM,
MacInnis MJ, et al. The 2018 Lake Louise Acute Mountain
Sickness Score. High Alt Med Biol 2018; 19: 4-6.
23. Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip
R, Houston C, et al. Acute mountain sickness in a general
tourist population at moderate altitudes. Ann Intern Med
1993; 118: 587-92.
25. Montgomery AB, Mills J, Luce JM. Incidence of acute
mountain sickness at intermediate altitude. JAMA 1989;
261: 732-4.
26. Bartsch P, Mairbaurl H, Maggiorini M, Swenson ER.
Physiological aspects of high-altitude pulmonary edema.
J Appl Physiol 2005; 98: 1101-10.
28. Luks AM, Swenson ER, Bärtsch P. Acute high-altitude
sickness. Eur Respir Rev 2017; 26: pii: 160096.
29. Hultgren HN, Honigman B, Theis K, Nicholas D. High-
altitude pulmonary edema at a ski resort. West J Med 1996;
164: 222-7.
30. Bird BA, Wright AD, Wilson MH, Johnson BG, Imray CH,
Birmingham Medical Research Expeditionary S. High
altitude ataxia--its assessment and relevance. Wilderness
Environ Med 2011; 22: 172-6.
31. Bartsch P, Swenson ER. Clinical practice: Acute high-
altitude illnesses. N Engl J Med 2013; 368: 2294-302.
32. West JB, American College of P, American Physiological S.
The physiologic basis of high-altitude diseases. Ann Intern
Med 2004; 141: 789-800.
33. Maggiorini M. High altitude-induced pulmonary oedema.
Cardiovasc Res 2006; 72: 41-50.
34. Grocott M, Montgomery H, Vercueil A. High-altitude
physiology and pathophysiology: implications and rel-
evance for intensive care medicine. Crit Care 2007; 11: 203.
35. Duplain H, Sartori C, Lepori M, Egli M, Allemann Y, Nicod
P, et al. Exhaled nitric oxide in high-altitude pulmonary
edema: role in the regulation of pulmonary vascular tone
and evidence for a role against inflammation. Am J Respir
Crit Care Med 2000; 162: 221-4.
36. Sartori C, Vollenweider L, Löffler BM, Delabays A, Nicod
P, Bärtsch P et al. Exaggerated endothelin release in high-
altitude pulmonary edema. Circulation 1999; 99: 2665-8.
37. Hackett PH, Roach RC. High-altitude illness. N Engl J
Med 2001; 345: 107-14.
39. Sanchez-Mascunano A, Masuet-Aumatell C, Morchon-
Ramos S, Ramon JM. Relationship of altitude mountain
sickness and smoking: a Catalan traveller‘s cohort study.
BMJ Open 2017; 7: e017058.
40. Edwards LM, Murray AJ, Tyler DJ, Kemp GJ, Holloway
CJ, Robbins PA, et al. The effect of high-altitude on human
skeletal muscle energetics: P-MRS results from the
Caudwell Xtreme Everest expedition. PLoS One 2010; 5:
e10681.
42. Rupert JL, Koehle MS. Evidence for a genetic basis for
altitude-related illness. High Alt Med Biol 2006; 7: 150-167.
44. Puthucheary Z, Skipworth JR, Rawal J, Loosemore M, Van
Someren K, Montgomery HE. The ACE gene and human
performance: 12 years on. Sports Med 2011; 41: 433-48.
45. Montgomery H, Clarkson P, Barnard M, Bell J, Brynes
A, Dollery C, et al. Angiotensin-converting-enzyme
gene insertion/deletion polymorphism and response to
physical training. Lancet 1999; 353: 541-5.
47. Droma Y, Hanaoka M, Ota M, Katsuyama Y, Koizumi T,
Fujimoto K, et al. Positive association of the endothelial
nitric oxide synthase gene polymorphisms with high-alti-
tude pulmonary edema. Circulation 2002; 106: 826-30.
48. Gertsch JH, Lipman GS, Holck PS, Merritt A, Mulcahy A,
Fisher RS, et al. Prospective, double-blind, randomized,
placebo-controlled comparison of acetazolamide versus
ibuprofen for prophylaxis against high altitude headache:
the Headache Evaluation at Altitude Trial (HEAT).
Wilderness Environ Med 2010; 21: 236-43.
49. Kanaan NC, Peterson AL, Pun M, Holck PS, Starling J,
Basyal B, et al. Prophylactic Acetaminophen or Ibuprofen
Results in Equivalent Acute Mountain Sickness Incidence
at High Altitude: A Prospective Randomized Trial.
Wilderness Environ Med 2017; 28: 72-8.
51. Nieto Estrada VH, Molano Franco D, Medina RD,
Gonzalez Garay AG, Marti-Carvajal AJ, Arevalo-
Rodriguez I. Interventions for preventing high altitude
illness: Part 1. Commonly-used classes of drugs. Cochrane
Database Syst Rev 2017; 6: CD009761.
52. Ritchie ND, Baggott AV, Andrew Todd WT. Acetazolamide
for the prevention of acute mountain sickness--a system-
atic review and meta-analysis. J Travel Med 2012; 19: 298-
307.
53. McIntosh SE, Hemphill M, McDevitt MC, Gurung TY,
Ghale M, Knott JR, et al. Reduced Acetazolamide Dosing in
Countering Altitude Illness: A Comparison of 62.5 vs 125
mg (the RADICAL Trial). Wilderness Environ Med 2019;
30: 12-21.
55. O‘Hara R, Serres J, Dodson W, Wright B, Ordway J, Powell
E, et al. The use of dexamethasone in support of high-
altitude ground operations and physical performance:
review of the literature. J Spec Oper Med 2014; 14: 53-8.
57. Gonzalez Garay A, Molano Franco D, Nieto Estrada VH,
Marti-Carvajal AJ, Arevalo-Rodriguez I. Interventions
for preventing high altitude illness: Part 2. Less comm-
only-used drugs. Cochrane Database Syst Rev 2018; 3:
CD012983.
58. Joyce KE, Lucas SJE, Imray CHE, Balanos GM, Wright AD.
Advances in the available non-biological pharmacother-
apy prevention and treatment of acute mountain sickness
and high altitude cerebral and pulmonary oedema. Expert
Opin Pharmacother 2018; 19: 1891-902.
59. Leshem E, Caine Y, Rosenberg E, Maaravi Y, Hermesh H,
Schwartz E. Tadalafil and acetazolamide versus acetazola-
mide for the prevention of severe high-altitude illness. J
Travel Med 2012; 19: 308-10.
60. Wang X, Chen H, Li R, Fu W, Yao C. The effects of
respiratory inhaled drugs on the prevention of acute
mountain sickness. Medicine (Baltimore) 2018; 97: e11788.
61. Deweber K, Scorza K. Return to activity at altitude after
high-altitude illness. Sports Health 2010; 2:2 91-300.
63. Meinders AJ, Bosch FH, Meinders AE. [Travelling to
high altitudes: do not increase fluid intake]. Ned Tijdschr
Geneeskd. 2011; 155: A3526.
64. Simancas-Racines D, Arevalo-Rodriguez I, Osorio D,
Franco JV, Xu Y, Hidalgo R. Interventions for treating
acute high altitude illness. Cochrane Database Syst Rev
2018; 6: CD009567.
65. Deshwal R, Iqbal M, Basnet S. Nifedipine for the treatment
of high altitude pulmonary edema. Wilderness Environ
Med 2012; 23: 7-10.
66. Xu Y, Liu Y, Liu J, Qian G. Meta-analysis of clinical efficacy
of sildenafil, a phosphodiesterase type-5 inhibitor on high
altitude hypoxia and its complications. High Alt Med Biol
2014; 15: 46-51.
67. Jones BE, Stokes S, McKenzie S, Nilles E, Stoddard GJ.
Management of high altitude pulmonary edema in the
Himalaya: a review of 56 cases presenting at Pheriche
medical aid post (4240 m). Wilderness Environ Med 2013;
24: 32-6.
70. Rodway GW, Edsell ME, Wong B, Windsor JS, Caudwell
Xtreme Everest Research G. Improving sleep at altitude: a
comparison of therapies. Wilderness Environ Med 2011;
22: 316-20.
71. Mason NP, Barry PW. Altitude-related cough. Pulm
Pharmacol Ther 2007; 20: 388-95.
72. Goebbels K, Gieseler U, Schoffl V, Kupper T. Cough and
dyspnoea of an asthmatic patient at Mt. Kilimanjaro: a
difficult differential diagnosis. Travel Med Infect Dis 2010;
8: 22-8.
73. Thompson AA, Baillie JK, Bates MG, Schnopp MF, Simpson
A, Partridge RW, et al. The citric acid cough threshold and
the ventilatory response to carbon dioxide on ascent to
high altitude. Respir Med 2009; 103: 1182-8.
74. Kuhn C, Apel C, Bertsch D, Grass M, Gschwandtl C, Hundt
N, et al. Inpatient treatment of trekkers and Nepalese
workers in the high-altitude environment of region 1996-
2011: A retrospective analysis. Travel Med Infect Dis 2018.
76. Sniffen JC, McFarland LV, Evans CT, Goldstein EJC.
Choosing an appropriate probiotic product for your pati-
ent: An evidence-based practical guide. PLoS One 2018;
13: e0209205.
78. Anand AC, Sashindran VK, Mohan L. Gastrointestinal
problems at high altitude. Trop Gastroenterol 2006; 27:
147-53.
79. Izadi M, Jonaidi-Jafari N, Pourazizi M, Alemzadeh-Ansari
MH, Hoseinpourfard MJ. Photokeratitis induced by
ultraviolet radiation in travelers: A major health problem.
J Postgrad Med 2018; 64: 40-46.
80. Bosch MM, Barthelmes D, Merz TM, Knecht PB, Truffer
F, Bloch KE, et al. New insights into changes in corneal
thickness in healthy mountaineers during a very-high-
altitude climb to Mount Muztagh Ata. Arch Ophthalmol
2010; 128: 184-9.
82. Bosch MM, Barthelmes D, Landau K. High altitude retinal
hemorrhages--an update. High Alt Med Biol 2012; 13: 240-
4.
Heimildir
Alls eru 82 heimildir við þessa
grein og þær eru allar í netútgáfunni.